ATE528301T1 - Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen - Google Patents

Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen

Info

Publication number
ATE528301T1
ATE528301T1 AT06722142T AT06722142T ATE528301T1 AT E528301 T1 ATE528301 T1 AT E528301T1 AT 06722142 T AT06722142 T AT 06722142T AT 06722142 T AT06722142 T AT 06722142T AT E528301 T1 ATE528301 T1 AT E528301T1
Authority
AT
Austria
Prior art keywords
producing substituted
substituted sulfoxide
compositions
sulfoxide compositions
pharmaceutically acceptable
Prior art date
Application number
AT06722142T
Other languages
English (en)
Inventor
Jingen Deng
Qin Yang
Yongle Chen
Jin Zhu
Qiwei Wang
Qiuya Huang
Xuemei Hou
Original Assignee
Livzon Pharmaceutical Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Livzon Pharmaceutical Group filed Critical Livzon Pharmaceutical Group
Application granted granted Critical
Publication of ATE528301T1 publication Critical patent/ATE528301T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
AT06722142T 2005-03-25 2006-03-24 Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen ATE528301T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200510058962 2005-03-25
PCT/CN2006/000490 WO2006099810A1 (en) 2005-03-25 2006-03-24 Substituted sulfoxide compounds, methods for preparing the same and use thereof

Publications (1)

Publication Number Publication Date
ATE528301T1 true ATE528301T1 (de) 2011-10-15

Family

ID=37023375

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06722142T ATE528301T1 (de) 2005-03-25 2006-03-24 Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen

Country Status (9)

Country Link
US (2) US20060217423A1 (de)
EP (1) EP1861391B1 (de)
JP (1) JP4837722B2 (de)
AT (1) ATE528301T1 (de)
AU (1) AU2006227032B2 (de)
CA (1) CA2597632C (de)
ES (1) ES2375298T3 (de)
HK (1) HK1114516A1 (de)
WO (1) WO2006099810A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4837722B2 (ja) * 2005-03-25 2011-12-14 リブゾン ファーマシューティカル グループ インク. 置換スルホキシド化合物、その調製方法、およびその使用方法
WO2008083319A1 (en) * 2006-12-29 2008-07-10 Il Yang Pharmaceutical Company, Ltd. Solid state forms of enantiopure ilaprazole
PL2102192T3 (pl) 2006-12-29 2013-04-30 Il Yang Pharmaceutical Company Ltd Postacie racemicznego ilaprazolu w stanie stałym
WO2009061529A1 (en) * 2007-11-06 2009-05-14 Tap Pharmaceutical Products, Inc. (+)-enantiomer of 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole and processing method eor preparing the same
KR101044880B1 (ko) * 2008-06-12 2011-06-28 일양약품주식회사 항궤양제 화합물의 합성에 유용한 중간체의 제조방법
CZ302548B6 (cs) * 2008-10-22 2011-07-07 Zentiva, A.S. Zpusob výroby 5-amino-2-[(4-methoxy-3-methyl-2-pyridyl)methylthio]-1H-benzimidazolu a 5-(1H-pyrrol-1-yl)-2-[(4-methoxy-3-methyl-2-pyridyl)methylthio]-1H-benzimidazolu
EP2486032A4 (de) 2009-10-09 2013-03-27 Hetero Research Foundation Racematspaltung substituierter 2-(2-pyridinylmethylsulfinyl)-1h-benzimidazole
CN102336788B (zh) * 2011-06-29 2014-08-27 涂家生 质子泵抑制剂氨基葡萄糖复盐
US11666562B2 (en) 2020-04-02 2023-06-06 Northwestern University Ilaprazole for inhibiting the release of enveloped viruses from cells
US20230265069A1 (en) * 2020-04-23 2023-08-24 Northwestern University Small Molecule Inhibitors That Block the Budding of Enveloped Viruses

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4035455A1 (de) 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
US5877192A (en) 1993-05-28 1999-03-02 Astra Aktiebolag Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
KR0179401B1 (ko) * 1994-02-28 1999-03-20 송택선 신규한 5-피롤릴-2-피리딜메틸설피닐벤즈이미다졸 유도체
SE504459C2 (sv) 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
KR20010065950A (ko) * 1999-12-30 2001-07-11 우재영 신규한 5-피롤릴-2-피리딜메틸설피닐 벤즈이미다졸유도체의 이성질체
EP1428825A4 (de) * 2001-09-18 2005-03-23 Zeria Pharm Co Ltd Benzimidazolderivate
WO2003089408A2 (en) * 2002-04-22 2003-10-30 Sun Pharmaceutical Industries Limited Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts
US6894066B2 (en) * 2002-05-09 2005-05-17 Bernard Charles Sherman Magnesium salt of S-omeprazole
EP1608649A2 (de) * 2003-03-28 2005-12-28 Sidem Pharma SA Verfahren zur herstellung von enantioselektiven sulfoxid-derivaten
JP4837722B2 (ja) 2005-03-25 2011-12-14 リブゾン ファーマシューティカル グループ インク. 置換スルホキシド化合物、その調製方法、およびその使用方法

Also Published As

Publication number Publication date
JP4837722B2 (ja) 2011-12-14
WO2006099810A1 (en) 2006-09-28
US8017784B2 (en) 2011-09-13
US20080234487A1 (en) 2008-09-25
ES2375298T3 (es) 2012-02-28
US20060217423A1 (en) 2006-09-28
AU2006227032A1 (en) 2006-09-28
HK1114516A1 (en) 2008-10-31
CA2597632A1 (en) 2006-09-28
EP1861391A4 (de) 2008-11-05
EP1861391A1 (de) 2007-12-05
EP1861391B1 (de) 2011-10-12
CA2597632C (en) 2012-05-15
AU2006227032B2 (en) 2010-02-25
JP2008534446A (ja) 2008-08-28

Similar Documents

Publication Publication Date Title
ATE528301T1 (de) Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen
NO2020010I1 (no) fostamatinib eller et farmasøytisk akseptabelt salt av fostamatinib, eller et hydrat, solvat eller N-oksid av fostamatinib eller det farmasøytisk akseptable saltet av fostamatinib, spesielt fostamatinib dinatrium, eventuelt på form av et hydrat
MX2007007845A (es) Sulfonilpirrolidinas, metodo para producir las mismas y su uso como medicamento.
TNSN06409A1 (en) Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
CY1116885T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου
ATE509622T1 (de) Amphetamin-ornithine konjugate sowie herstellungs-und verwendungsverfahren
ATE482966T1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
WO2007034279A3 (en) C3a antagonists and pharmaceutical compositions thereof
ATE556074T1 (de) Neue imidazoä1,5-aüpyridinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten
MX2007012212A (es) 1h-pirazol 4-carboxilamidas, su preparacion y su uso como 11-beta-hidroxiesteroide deshidrogenasa.
DE502005001841D1 (de) Verfahren zur herstellung von 1,4-diphenylazetidinon-derivaten
TW200738692A (en) New substituted glycinamides, process for their manufacture and use thereof as medicaments
EA200600223A1 (ru) Замещённый 2-аминотетралины для лечения депрессии
EA200800502A1 (ru) Соединения 3-аминокарбазола, фармацевтическая композиция, содержащая указанные соединения, и способ их получения
ATE386725T1 (de) Heterocyclylverbindungen
DE502005000428D1 (de) Verfahren zur Herstellung von 1,2-Diaminocyclohexan-Platin(II)-Komplexen
TW200716152A (en) Substituted 1,2-ethylendiamines, medicaments comprising said compound, their use and their method of manufacture
EA200601845A1 (ru) НОВЫЕ β-АГОНИСТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ
DE602005016282D1 (de) Verfahren zur herstellung von camptothecin-derivaten
DE602005014280D1 (de) Verfahren zur herstellung von ä1,4,5ü-oxadiazepinderivaten
WO2007048841A3 (de) Neue indol-haltige beta-agonisten, verfahren zu deren herstellung und deren verwendung als arzneimittel
ATE466003T1 (de) Herstellung von 2-aminothiazol-5- carbonsäurederivaten
EA200870223A1 (ru) Производные бензоизоиндола для лечения боли
WO2006080043A3 (en) Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties